Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + Chemotherapy in Advanced Squamous NSCLC
NCT02513342Phase 4Unknown
- Sponsor
- Nanjing Ningqi Pharmaceutical Technology
- Start
- Mar 2015
- Primary completion
- Oct 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in squamous cell carcinoma of the lung (SCCL), sponsored by Nanjing Ningqi Pharmaceutical Technology. Status: unknown.
02
Drugs
endostar
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT02513342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513342.